Integrative Medicine Institute (IMI) – Trademark Portfolio
Entity Type: 16
Integrative Medicine Institute (IMI) holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CARE-WRITER. The owner is based in Portland, OR.
2437 NW Overton
Portland, OR 97210
Showing of trademarks Trademarks
Trademark Classifications
Integrative Medicine Institute (IMI)'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Integrative Medicine Institute (IMI) have?
Integrative Medicine Institute (IMI) has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Integrative Medicine Institute (IMI) file in?
Integrative Medicine Institute (IMI) files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Integrative Medicine Institute (IMI)'s most well-known trademarks?
Integrative Medicine Institute (IMI)'s registered trademark portfolio includes well-known marks such as CARE-WRITER. These are among 1 currently registered trademark in the portfolio.
What is Integrative Medicine Institute (IMI)'s trademark registration success rate?
Integrative Medicine Institute (IMI) has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.